- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zeria Pharmaceutical Co Ltd (4559)
Zeria Pharmaceutical Co Ltd stock price live, this page displays TYO 4559 stock exchange data. View the 4559 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zeria Pharmaceutical Co Ltd real time stock price chart below.
What Is the Zeria Pharmaceutical Co Ltd Stock Price Today?
The Zeria Pharmaceutical Co Ltd stock price today is 2,150.0.
What Is the Stock Symbol for Zeria Pharmaceutical Co Ltd?
The stock symbol for Zeria Pharmaceutical Co Ltd is "4559."
What Stock Exchange Does Zeria Pharmaceutical Co Ltd Trade On?
Zeria Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Zeria Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zeria Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4559 quote. (ISIN: JP3428850006)
What Is the Zeria Pharmaceutical Co Ltd Stock Price Today?
The Zeria Pharmaceutical Co Ltd stock price today is 2,150.0.
What Is the Stock Symbol for Zeria Pharmaceutical Co Ltd?
The stock symbol for Zeria Pharmaceutical Co Ltd is "4559."
What Stock Exchange Does Zeria Pharmaceutical Co Ltd Trade On?
Zeria Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Zeria Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zeria Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4559 quote. (ISIN: JP3428850006)
Tokyo
Currency in JPY
2,150.0
+32.0(+1.51%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,119.0
2,160.0
52 wk Range
1,878.0
2,434.0
4559 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,119.02,160.0
52 wk Range
1,878.02,434.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.36%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.36%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4559 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
2,600.0
Upside
+20.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2,600.0
(+20.93% Upside)
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
19.65 / --
Revenue / Forecast
21.45B / 22.75B
Compare 4559 to Peers and Sector
Metrics to compare | 4559 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4559PeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.3x | 15.8x | −0.3x | |
PEG Ratio | 0.55 | 0.14 | 0.00 | |
Price/Book | 0.9x | 1.1x | 2.6x | |
Price / LTM Sales | 1.0x | 1.6x | 3.1x | |
Upside (Analyst Target) | 20.9% | 13.3% | 48.5% | |
Fair Value Upside | Unlock | 8.3% | 6.3% | Unlock |
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; and non-steroidal anti-inflammatory ophthalmic solutions. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. Further, the company engages in insurance agency and real estate business. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Zeria Pharmaceutical (4559) Stock Price Today?
The Zeria Pharmaceutical stock price today is 2,150.0 JPY.
What Stock Exchange Does Zeria Pharmaceutical Trade On?
Zeria Pharmaceutical is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Zeria Pharmaceutical?
The stock symbol for Zeria Pharmaceutical is "4559."
Does Zeria Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Zeria Pharmaceutical dividend yield is 2.36%.
What Is the Zeria Pharmaceutical Market Cap?
As of today, Zeria Pharmaceutical market cap is 93.36B JPY.
What Is Zeria Pharmaceutical's Earnings Per Share (TTM)?
The Zeria Pharmaceutical EPS (TTM) is 186.7.
When Is the Next Zeria Pharmaceutical Earnings Date?
Zeria Pharmaceutical will release its next earnings report on Nov 04, 2026.
From a Technical Analysis Perspective, Is 4559 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Zeria Pharmaceutical Stock Split?
Zeria Pharmaceutical has split 1 times.
How Many Employees Does Zeria Pharmaceutical Have?
Zeria Pharmaceutical has 1748 employees.
What is the current trading status of Zeria Pharmaceutical (4559)?
As of Aug 20, 2026, Zeria Pharmaceutical (4559) is trading at a price of 2,150.0 JPY, with a previous close of 2,118.0 JPY. The stock has fluctuated within a day range of 2,119.0 JPY to 2,160.0 JPY, while its 52-week range spans from 1,878.0 JPY to 2,434.0 JPY.
What Is Zeria Pharmaceutical (4559) Price Target According to Analysts?
The average 12-month price target for Zeria Pharmaceutical is 2,600.0 JPY, with a high estimate of 2600 JPY and a low estimate of 2600 JPY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +20.93% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.